PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: RNCOS E-Services (P) Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

FICCI Recommends Various Tax Reductions on Pharmaceutical Industry - Federation of Indian Chambers of Commerce and Industry, proposing its pre budget list of wishes, has recommended the government to extend 150% weighted deduction on investments pharmaceutical companies make for R&D activities
FICCI Recommends Various Tax Reductions on Pharmaceutical Industry

 

NewswireToday - /newswire/ - Delhi, New Delhi, India, 2006/12/16 - Federation of Indian Chambers of Commerce and Industry, proposing its pre budget list of wishes, has recommended the government to extend 150% weighted deduction on investments pharmaceutical companies make for R&D activities.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

FICCI (Federation of Indian Chambers of Commerce and Industry), in its pre budget demand list, has urged that the government should extend 150% weighted deduction on investments made by pharmaceutical companies in building and land for the purposes of R&D (Research and Development).

The federation has also solicited waiver of excise and custom duties and service tax for revenue expenditure, capital goods, and services received by research and development units. In its pre budget memo to govt., FICCI has recommended that chosen life saving drugs ought to be given full exemption from custom duty. Today, these drugs attract custom duty ranging between 5%-12.5%.

The federation has also asked for reduction in excise duty on pharmaceuticals from 16% to 8%. It has also sought a review of duty structure and naptha rate. As per FICCI, the levy on naptha for chemical industry needs to be brought at same level as naptha for plastics, which is at zero percent. Naptha, which is a raw material for most chemicals, bulk drugs and fine chemicals, attracts ten percent of import duties. On the other hand, either zero percent or confessional rate of duty is attracted by life-saving drugs.

FICCI has also suggested that diminution on MRP in pharmaceutical industry ought to be raised to 45% from its current level of 40%.

As per the views expressed by a senior Research Analyst at RNCOS, who has recently researched a report on "World Pharmaceutical Market (2007)", the market for pharmaceutical products is expanding rapidly. Naptha is allowed at zero percent duty by China, which is an archrival of Indian pharmaceutical industry. This makes an adverse affect on the global competitiveness of Indian pharmaceutical companies.

"World Pharmaceutical Market (2007)" report also addresses the issues and facts that are critical to the success of pharmaceutical industry worldwide, such as:

- Emerging trends in the global pharmaceutical industry
- Who are the key players in this sector?
- Get an insight into the trends in market performance
- Pinpoint sectors of growth and identify the driving factors
- Identify market, brand leaders and understand the competitive environment
- What are the key challenges and strategies associated with global pharmaceutical industry?

About the report

The report provides an exclusive overview of global pharmaceutical industry. It provides authentic past and current performance data for the pharmaceutical industry. The report is a must read for investors, businesses, researchers, and individuals willing to acquire an in-depth knowledge of the world pharmaceutical industry.

About RNCOS

RNCOS, incorporated in 2002, provides Market Research Reports for your business needs and aims to put an end to your information pursuit. Our expertise in gathering global business information for industry research, corporate training, growth consulting, and business consulting, brings reputed companies and firms to us for business enhancement solutions. We can be your one-stop-shop for Industry research information and niche market analysis.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: RNCOS E-Services (P) Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


FICCI Recommends Various Tax Reductions on Pharmaceutical Industry

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Shushmul Maheshwari 
+91 12 04224700 press[.]rncos.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any RNCOS E-Services (P) Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From RNCOS E-Services (P) Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)